MarketResearchReports.Biz announces addition of new report “Global Human Capital Management Market 2012-2016” to its database
Albany, NY -- (SBWIRE) -- 11/14/2013 -- Global Human Capital Management Market 2012-2016
TechNavio's analysts forecast the Global Human Capital Management market to grow at a CAGR of 10.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the streamlining of human resource operations. The Global HCM market has also been witnessing the emergence of SaaS-based HCM solutions. However, the fragmentation of the market could pose a challenge to the growth of this market.
To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/global-human-capital-management-market-2012-2016
TechNavio's report, the Global HCM Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Human Capital Management market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Infor Global Solutions, Kronos Inc., Oracle Corp., and SAP AG.
Other vendors mentioned in the report are Kenexa Corp., Microsoft Corp., SumTotal Systems Inc., Ultimate Software, and Workday Inc.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179047
Key questions answered in this report:
- What will the market size be in 2016 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENT
1. Executive Summary
2. Scope of the Report
2.1 Market Overview
2.2 Product Offerings
3. Market Research Methodology
3.1 Market Research Process
3.2 Research Design
3.3 Research Methodology
4. List of Abbreviations
6. Market Landscape
7. Geographical Segmentation
8. Key Leading Countries
9. Buying Criteria
10. Market Growth Drivers
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/179047
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
17. Key Vendor Analysis
18. Other Reports in this Series
Apoptosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/apoptosis-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Apoptosis is a programmed natural process of cell death in the body which results from natural stimuli in order to protect against viral infection, unusual cell division and cells with damaged genetic material. However malfunctioning of apoptosis can trigger uncontrolled and non regulated cell death related to degenerative disorders such as Parkinson’s disease and Alzheimer’s. Defective apoptosis process has been one of the most common and leading causes for cancer wherein the affected cells instead of undergoing apoptosis continue to proliferate and mutate. Thus development of apoptosis modulating drugs has recently been witnessing spectacular growth in the treatment for cancer, CNS diseases, and chronic inflammation or autoimmunity disorders.
The global apoptosis market is categorized by:
Drug class and consumables
- Direct apoptogens
- First generation indirect apoptogens
- Second generation indirect apoptogens
- Reagents and kits
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/176546
- Neurodegenerative diseases
Currently, North America dominates the global apoptosis market and is followed by Europe due to existence of huge potential for apoptosis modulating therapeutics and rising popularity of targeted cancer therapy. Emerging economies of Asia-Pacific, Latin America, Middle East and Africa are also expected to undergo rapid growth in the apoptosis market due to the rising incidences of cancer and unmet treatment needs in such developing regions.
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biological drugs are biological medical products whose active drug substance is extracted by using living organism. The active substance is derived from living organism by the usage of recombinant DNA technology. These drugs offer better treatment solutions than synthetic drugs owing to greater accuracy and fewer side effects. Biological drugs are mainly made of monoclonal antibodies (mAbs) that help to fight with the disease. Monoclonal antibodies have the capability of targeting specific area in the body that requires drug treatment hence producing accurate results. Majorly biologic drugs are given for the treatment of diseases such as HIV/AIDS, Alzheimer’s diseases, cancers and others. Moreover, biologic drugs are also expected to find a solution for the large portion of retired population which is more prone to chronic diseases.
Global biological drugs market is growing at substantial rate owing to the drug accuracy and increase in chronic diseases. In addition, biologic drugs have shown a better outcome in long term and offer a better quality of life. There are approximately 150 biologic drugs commercially available in the markets which are being used to treat diseases such as asthma, irritable bowel syndrome, rheumatoid arthritis, cancer and others. For example, Avastin for the treatment of lung cancer and Cerezyme for Gaucher disease are commercially available and cost about USD 100,000 and USD 300,000 per year respectively. However, half of the biological drugs are about to lose their patent protection and as a result cheaper alternative biogeneric products are expected to enter in to the market. On the contrary, cost of the biologic drugs is one the major restraining factor for the growth of this market. Biologic drugs are costly as compared to other drugs but are likely to become cheaper in near future. Owing to the potential benefits of the biologic drugs they have been put on fast track FDA approval process.
Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/177969
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948